<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>DARU Journal of Pharmaceutical Sciences</JournalTitle><Volume>17</Volume><Issue>3</Issue><PubDate PubStatus="epublish"><Year>2015</Year><Month>12</Month><Day>13</Day></PubDate></Journal><ArticleTitle>Combination of inulin and time dependent polymethacrylates as a coating system to achieve colonic delivery of indomethacin</ArticleTitle><FirstPage>199</FirstPage><LastPage>208</LastPage><AuthorList><Author><FirstName>A</FirstName><LastName>Akhgari</LastName></Author><Author><FirstName>H</FirstName><LastName>Afrasiabi Garekani</LastName></Author><Author><FirstName>F</FirstName><LastName>Sadeghi</LastName></Author></AuthorList><History><PubDate PubStatus="received"><Year>2015</Year><Month>12</Month><Day>13</Day></PubDate></History><Abstract>Background:In the previous study it was shown that films prepared from inulin (In) in combination with Eudragit RS (ERS) and RL (ERL) were susceptible to inulinase. Purpose: The aim of this work was to assess the suitability of these combinations for colonic delivery of indomethacin.
Methods: Indomethacin was loaded onto non-pareil seeds using fluidized bed apparatus to produce pellets with 20% w/w drug load. Drug loaded pellets were coated with In-ERS in the ratios of 20:80 and 30:70, or In-ERL in the ratio of 20:80 to different coating loads. The release of drug was examined in simulated gastric (for 2 hrs) and small intestine and in the presence of inulinase in simulated colonic medium (for 12 or 24 hrs).
Results: The results of this study revealed that incorporation of inulin as a bacterially degradable polysaccharide into ERS or ERL could modulate drug release. Coating level up to 15% significantly affected drug release from In-ERL or In-ERS coated pellets. However further increase in coating load to 20% had no significant effect on drug release from In-ERL coated pellets (f1=9.39). Drug release from In-ERL coated pellets was faster and showed some pH dependency.
Conclusions: Formulation coated with In-ERS (20:80) and coating level of 20% was considered more appropriate for colon delivery of indomethacin, as drug release was pH independent and formulation was resistant to drug release in the upper GI media for up to 7 hrs. This formulation was also susceptible to inulinase and released about 40% of indomethacin in the simulated colonic media.</Abstract><web_url>https://daru.tums.ac.ir/index.php/daru/article/view/545</web_url><pdf_url>https://daru.tums.ac.ir/index.php/daru/article/download/545/434</pdf_url></Article></Articles>
